Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Anlotinib Dihydrochloride in Unresectable Hepatocellular Carcinoma: NCT07746960 Clinical Landscape Report 2026
9 min read
Anlotinib Dihydrochloride in Unresectable Hepatocellular Carcinoma: NCT07746960 Clinical Landscape Report 2026
16 September 2026
NCT07746960 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
ACG102 in Systemic Lupus Erythematosus: NCT07749430 Clinical Landscape Report 2026
9 min read
ACG102 in Systemic Lupus Erythematosus: NCT07749430 Clinical Landscape Report 2026
16 September 2026
NCT07749430 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
RO7845860 (F. Hoffmann-La Roche Ltd.) in Multiple sclerosis relapse: NCT07749157 Clinical Landscape Report 2026
9 min read
RO7845860 (F. Hoffmann-La Roche Ltd.) in Multiple sclerosis relapse: NCT07749157 Clinical Landscape Report 2026
16 September 2026
NCT07749157 clinical landscape for Multiple sclerosis relapse: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mepolizumab in Pulmonary Disease, Chronic Obstructive: NCT07749001 Clinical Landscape Report 2026
9 min read
Mepolizumab in Pulmonary Disease, Chronic Obstructive: NCT07749001 Clinical Landscape Report 2026
16 September 2026
NCT07749001 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
GT802 (Vivacta Biotechnology (Shanghai) Co., Ltd.) in Multiple Sclerosis: NCT07748637 Clinical Landscape Report 2026
9 min read
GT802 (Vivacta Biotechnology (Shanghai) Co., Ltd.) in Multiple Sclerosis: NCT07748637 Clinical Landscape Report 2026
16 September 2026
NCT07748637 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07748611 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07748611 Clinical Landscape Report 2026
16 September 2026
NCT07748611 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
CHM-029 in Acute myeloid leukemia with mutated NPM1: NCT07751991 Clinical Landscape Report 2026
9 min read
CHM-029 in Acute myeloid leukemia with mutated NPM1: NCT07751991 Clinical Landscape Report 2026
16 September 2026
NCT07751991 clinical landscape for Acute myeloid leukemia with mutated NPM1: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
Read →
Belantamab mafodotin in Relapse multiple myeloma: NCT07748689 Clinical Landscape Report 2026
9 min read
Belantamab mafodotin in Relapse multiple myeloma: NCT07748689 Clinical Landscape Report 2026
16 September 2026
NCT07748689 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
[18F]Florzolotau in Alzheimer Disease: NCT07752784 Clinical Landscape Report 2026
9 min read
[18F]Florzolotau in Alzheimer Disease: NCT07752784 Clinical Landscape Report 2026
16 September 2026
NCT07752784 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Anifrolumab-FNIA in Systemic Lupus Erythematosus: NCT07751848 Clinical Landscape Report 2026
9 min read
Anifrolumab-FNIA in Systemic Lupus Erythematosus: NCT07751848 Clinical Landscape Report 2026
16 September 2026
NCT07751848 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Pemetrexed Disodium Hydrate in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07751536 Clinical Landscape Report 2026
9 min read
Pemetrexed Disodium Hydrate in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07751536 Clinical Landscape Report 2026
16 September 2026
NCT07751536 clinical landscape for Metastatic Malignant Neoplasm to the Leptomeninges: endpoints, sponsor, phase, geography, readouts, asset context and deve…
Read →
Tirzepatide in Pouchitis: NCT07756359 Clinical Landscape Report 2026
9 min read
Tirzepatide in Pouchitis: NCT07756359 Clinical Landscape Report 2026
16 September 2026
NCT07756359 clinical landscape for Pouchitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →